Cargando…
Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19
The current coronavirus (COVID-19) pandemic is exacerbated by the absence of effective therapeutic agents. Notably, patients with COVID-19 and comorbidities such as hypertension and cardiac diseases have a higher mortality rate. An efficient strategy in response to this issue is repurposing drugs wi...
Autores principales: | Cho, Junhyung, Lee, Young Jae, Kim, Je Hyoung, Kim, Sang il, Kim, Sung Soon, Choi, Byeong-Sun, Choi, Jang-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530981/ https://www.ncbi.nlm.nih.gov/pubmed/33004837 http://dx.doi.org/10.1038/s41598-020-72879-7 |
Ejemplares similares
-
Ouabain and Digoxin Activate the Proteasome and the Degradation of the ERα in Cells Modeling Primary and Metastatic Breast Cancer
por: Busonero, Claudia, et al.
Publicado: (2020) -
Cardiac Glycosides Ouabain and Digoxin Interfere with the Regulation of Glutamate Transporter GLAST in Astrocytes Cultured from Neonatal Rat Brain
por: Nguyen, Khoa T. D., et al.
Publicado: (2010) -
Ouabaïne
Publicado: (1891) -
Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants
por: Cho, Junhyung, et al.
Publicado: (2023) -
Antiviral activity of ouabain against a Brazilian Zika virus strain
por: Carvalho, Deyse Cristina Madruga, et al.
Publicado: (2022)